0 items USD 0.00Search
- Did you mean
- non small cell long cancer
Your search for "non%20small%20cell%20lung%20cancer%20" gave back 190703 results.
Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Proto Oncogene Tyrosine Protein Kinase ROS - Pipeline Review, H1 2020 Summary According to the recently published report 'Proto Oncogene...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
5' Nucleotidase - Pipeline Review, H2 2019 Summary 5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - 5′-...
Catalog:
Global Markets Direct
August 2019
Price: USD 3,500.00
The global Lung Cancer Diagnosis and Therapeutics market size was valued at US$ million in 2023. With growing demand in downstream market, the Lung...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Highlights The global Lung Cancer Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Summary Publisher estimates that the Drugs for Non-small Cell Lung Cancer market size will grow from xxx Million USD in 2020 to xxxx Million USD by...
Catalog:
HYR
June 2021
Price: USD 2,000.00
Summary The Drugs for Non-small Cell Lung Cancer market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of...
Catalog:
HYR
February 2021
Price: USD 2,000.00
Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review...
Catalog:
Global Markets Direct
October 2018
Price: USD 3,500.00
Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct...
Catalog:
Global Markets Direct
November 2022
Price: USD 2,500.00
Small-Cell Lung Cancer - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Proto Oncogene Tyrosine Protein Kinase Src - Pipeline Review, H1 2020 Summary Proto Oncogene Tyrosine Protein Kinase Src (Proto Oncogene c Src or...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review...
Catalog:
Global Markets Direct
April 2018
Price: USD 3,500.00
Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H2 2018...
Catalog:
Global Markets Direct
July 2018
Price: USD 3,500.00
Proto Oncogene Tyrosine Protein Kinase Src - Pipeline Review, H2 2019 Summary Proto Oncogene Tyrosine Protein Kinase Src (Proto Oncogene c Src or...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Summary Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment...
Catalog:
HYR
April 2021
Price: USD 2,000.00
